Lindbrook Capital’s Privia Health PRVA Stock Holding History

Lindbrook Capital’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$898	Buy	+40	New	+$929	﹤0.01%	2494
2024 Q2	–	Sell	-25	Closed	-$490	–	2825
2024 Q1	$490	Sell	25 -17	-40%	-$359	﹤0.01%	2520
2023 Q4	$967	Sell	42 -12	-22%	-$269	﹤0.01%	2471
2023 Q3	$1.24K	Sell	54 -613	-92%	-$15.6K	﹤0.01%	2291
2023 Q2	$17.4K	Buy	667 +148	+29%	+$3.91K	﹤0.01%	1161
2023 Q1	$14.3K	Sell	519 -43	-8%	-$1.14K	﹤0.01%	1229
2022 Q4	$12.8K	Buy	562 +228	+68%	+$6.35K	﹤0.01%	1307
2022 Q3	$11K	Buy	+334	New	+$12.4K	﹤0.01%	1290

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lindbrook Capital's PRVA Position: Q1 2025 in Review

Lindbrook Capital opened a new position in Privia Health (PRVA) in Q1 2025: 40 shares worth $898. The stake represents ﹤0.01% of the portfolio and ranks #2494 among its holdings. This is a return to the name: Lindbrook Capital previously reported a position in PRVA as recently as Q1 2024.

Lindbrook Capital first reported a position in PRVA in Q3 2022 and has held it in 8 quarters since. The position peaked at $17.4K in Q2 2023. 248 funds tracked by Wall St. Rank hold PRVA as of Q1 2025.

Lindbrook Capital held 40 shares of Privia Health worth $898 as of Q1 2025.
Privia Health was a new Lindbrook Capital position in Q1 2025.
Privia Health made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2494 holding.
Lindbrook Capital first reported a position in Privia Health in Q3 2022 and has held it in 8 quarters since.
Lindbrook Capital's Privia Health position peaked at $17.4K in Q2 2023.
248 funds tracked by Wall St. Rank held Privia Health as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.